首页> 外文会议>ASME annual dynamic systems and control conference >NEW ALGORITHM TO DESIGN REAL TIME OPTIMAL AND ROBUST ULTRAFILTRATION RATES IN CHRONIC KIDNEY DISEASE TO PREVENT CARDIOVASCULAR MORBIDITY AND MORTALITY
【24h】

NEW ALGORITHM TO DESIGN REAL TIME OPTIMAL AND ROBUST ULTRAFILTRATION RATES IN CHRONIC KIDNEY DISEASE TO PREVENT CARDIOVASCULAR MORBIDITY AND MORTALITY

机译:在慢性肾脏疾病中设计实时最佳和强效超滤速率的新算法,以预防心血管疾病的死亡率和死亡率

获取原文

摘要

Hemodialysis (HD) is a necessary treatment for end-stage kidney disease (ESKD) patients in order to prevent cardiovascular morbidity and mortality that may be related to the hemodynamic effects of rapid ultrafiltration. Despite significant advances in HD technology, only half of ESKD patients treated with HD survive more than 3 years. Fluid management remains one of the most challenging aspects of HD care, with serious implications for morbidity and mortality. In this paper, we develop a novel algorithm to design real time optimal, robust ultrafiltration rates based on actual HD data to identifying the parameters of a fluid volume model of an individual patient during HD. Our design achieves, if exists, an optimal ultrafiltration profile for the identified nominal model under maximum ultrafiltration and hematocrit constraints and guarantees that these constraints are satisfied over a pre-defined set of parameter uncertainty. We demonstrate the robust performance of our algorithm through a combination of clinical data and simulations.
机译:血液透析(HD)是终末期肾脏疾病(ESKD)患者的必要治疗,以防止可能与快速超滤的血流动力学效应相关的心血管疾病和死亡。尽管高清技术取得了重大进步,但只有一半接受EHD治疗的ESKD患者可以生存3年以上。液体管理仍然是高清护理中最具挑战性的方面之一,对发病率和死亡率具有严重影响。在本文中,我们开发了一种新颖的算法,可根据实际HD数据设计实时最佳,鲁棒的超滤速率,以识别HD期间各个患者的体液模型的参数。如果存在,我们的设计可以在最大超滤和血细胞比容约束下,为所识别的标称模型实现最佳的超滤特性,并确保在预定义的参数不确定性条件下满足这些约束。我们通过结合临床数据和模拟来证明我们算法的鲁棒性能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号